The studies developed by the European Working Party on Systemic Lupus Erythematosus and the European Forum on Antiphospholipid Antibodies stress the importance of the creation of international networks devoted to the study of autoimmune diseases and the need for centres of excellence in the management of these conditions. This article analyses the importance of such centres and networks in Europe.
4 Vasconcelos C . Autoimmune disease units in hospitals. Ann NY Acad Sci2009 (in press).
5.
5 American autoimmune related diseases association. In focus vol. 10. 2002.
6.
6 Shoenfeld Y Selmi C Zimlichman E Gershwin ME . The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. J Autoimmun2008; 31: 325–330.
7.
8.
9.
9 Shoenfeld Y Cervera R Haass BM . EASI—The European autoimmunity standardisation initiative. A new initiative that can contribute to agreed diagnostic models of diagnosing autoimmune disorders throughout Europe. Ann NY Acad Sci2007; 1109: 138–144.
10.
10 Sailler L . Rituximab off label use for difficult-to-treat auto-immune diseases: reappraisal of benefits and risks. Clin Rev Allergy Immunol2008; 34: 103–110.
11.
11 Ramos-Casals M Brito-Zerón P Muñoz S Soto MJ ; The BIOGEAS STUDY Group.A systematic review of the off-label use of biological therapies in systemic autoimmune diseases. Medicine (Baltimore)2008; 87: 345–364.
12.
12 Amoura Z Haroche J Piette JC . Lupus systémique: les traitements du futur. Rev Med Interne2008; 29: 718–724.
